|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 07-23 | GE HealthCare says CFO Saccaro to step down; reports preliminary Q2 results | RE |
| 07-23 | AI shortens drug discovery to around 1 year in China, Insilico CEO says | RE |
| Market Cap | 140B 123B 114B 105B 197B 13,469B 200B 1,357B 530B 6,622B 525B 514B 22,895B | P/E 2026 * |
12.5x | P/E 2027 * | 12.9x |
|---|---|---|---|---|---|
| Enterprise Value | 189B 166B 155B 142B 266B 18,223B 271B 1,835B 717B 8,959B 710B 695B 30,976B | EV / Sales 2026 * |
3.06x | EV / Sales 2027 * | 3.08x |
| Free-Float |
59.06% | Yield 2026 * |
7.02% | Yield 2027 * | 7.08% |
Last Transcript: Pfizer Inc
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 64 | 31/12/2018 |
David Denton
DFI | Director of Finance/CFO | 60 | 01/05/2022 |
| Chief Tech/Sci/R&D Officer | - | 31/12/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
Suzanne Johnson
BRD | Director/Board Member | 68 | 31/08/2007 |
Shantanu Narayen
BRD | Director/Board Member | 62 | 26/09/2013 |
Albert Bourla
CHM | Chairman | 64 | 31/12/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.86% | +1.43% | +47.17% | +161.40% | 1,067B | ||
| +1.59% | +4.09% | +56.51% | +52.79% | 635B | ||
| +0.95% | +1.91% | +36.30% | +83.13% | 458B | ||
| +1.60% | +6.25% | +37.00% | +30.00% | 347B | ||
| -0.60% | +1.52% | +36.67% | +39.80% | 295B | ||
| -0.14% | +0.60% | +17.29% | +18.19% | 262B | ||
| +0.09% | -2.82% | -29.09% | -41.29% | 216B | ||
| +1.22% | +2.66% | +22.66% | +59.81% | 203B | ||
| -1.18% | -3.70% | +11.28% | +67.43% | 161B | ||
| Average | +0.49% | +1.33% | +26.20% | +52.36% | 404.78B | |
| Weighted average by Cap. | +0.76% | +1.95% | +35.99% | +78.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 61.75B 54.23B 50.43B 46.28B 86.96B 5,946B 88.3B 599B 234B 2,923B 232B 227B 10,108B | 59.37B 52.15B 48.5B 44.5B 83.61B 5,718B 84.9B 576B 225B 2,811B 223B 218B 9,719B |
| Net income | 10.63B 9.33B 8.68B 7.97B 14.97B 1,023B 15.2B 103B 40.27B 503B 39.89B 39.03B 1,740B | 10.27B 9.02B 8.39B 7.7B 14.46B 989B 14.68B 99.59B 38.91B 486B 38.55B 37.71B 1,681B |
| Net Debt | 49.36B 43.36B 40.32B 37B 69.52B 4,754B 70.59B 479B 187B 2,337B 185B 181B 8,081B | 43.17B 37.91B 35.26B 32.35B 60.79B 4,157B 61.73B 419B 164B 2,044B 162B 159B 7,066B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions


















